Nirvana Life Sciences (XCNQ:NIRV) Market Cap : C$3.62 Mil (As of Dec. 11, 2024)

Nirvana Life Sciences Market Cap Chart

Nirvana Life Sciences Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Market Cap	Get a 7-Day Free Trial															3.91	1.02	1.69	1.93	2.17

Competitive Comparison of Nirvana Life Sciences's Market Cap

For the Biotechnology subindustry, Nirvana Life Sciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nirvana Life Sciences's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nirvana Life Sciences's Market Cap distribution charts can be found below:

* The bar in red indicates where Nirvana Life Sciences's Market Cap falls into.

Nirvana Life Sciences Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Nirvana Life Sciences's Market Cap for the fiscal year that ended in Apr. 2023 is calculated as

Nirvana Life Sciences's Market Cap for the quarter that ended in Jan. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nirvana Life Sciences  (XCNQ:NIRV) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Nirvana Life Sciences Market Cap Related Terms

Thank you for viewing the detailed overview of Nirvana Life Sciences's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Nirvana Life Sciences Business Description